Coccidioidomycosis in rheumatology patients: Incidence and potential risk factors

Annals of the New York Academy of Sciences

Volumn 1111, Issue , 2007, Pages 343-357

  Mertz, Lester E ^a   Blair, Janis E ^a  

^a MAYO CLINIC   (United States)

Author keywords

Coccidioidomycosis; Corticosteroids; Disease modifying antirheumatic drug; Immunosuppression; Incidence; Rheumatoid arthritis; Tumor necrosis factor inhibitors

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; PYRROLE; TUMOR NECROSIS FACTOR DERIVATIVE;

ADULT; AGED; COCCIDIOIDOMYCOSIS; CONFERENCE PAPER; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; RISK FACTOR; THORAX; UNITED STATES;

EID: 35348900733     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1406.027     Document Type: Conference Paper

References (14)

1. KEANE, J., S. GERSHON, R.P. WISE, et al. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345: 1098-1104.
2. PHYSICIANS DESK REFERENCE ONLINE. Remicade for IV injection (Centocor). Available from http://www.pdr.net/login/ Login.aspx.
3. DORAN, M.F., C.S. CROWSON, G.R. POND, et al. 2002. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 46: 2287-2293.
4. DORAN, M.F., C.S. CROWSON, G.R. POND, et al. 2002. Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 46: 2294-2300.
5. ST. CLAIR, E.W., D.M. VAN DER HEIJDE, J.S. SMOLEN, et al. 2004. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum. 50: 3432-3443.
6. GALGIANI, J. 2005. Coccidioides species. In: G.L. Mandell, J.E. BENNETT, R. DOLIN, Eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th edition. :3040-3051. Elsevier/Churchill Livingstone. Philadelphia, PA.
7. LOGAN, J.L., J.E. BLAIR & J.N. GALGIANI. 2001. Coccidioidomycosis complicating solid organ transplantation. Semin. Respir. Infect. 16: 251-256.
8. BERGSTROM, L., D.E. YOCUM, J. TESSER, et al. 2002. Coccidiomycosis (Valley Fever) occuring during infliximab therapy [abstract]. Arthritis Rheum. 46 Suppl. 9: S169.
9. BERGSTROM, L., D.E. YOCUM, N.M. AMPEL, et al. 2004. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum. 50: 1959-1966.
10. ARIZONA, DEPARTMENT OF HEALTH SERVICES, DIVISION OF PUBLIC HEALTH SERVICES [homepage on the Internet]. Monthly summary of selected reportable diseases, September 2006 [cited 2006 Aug]. Available from http://www.azdhs.gov/phs/oids/stats/pdf/monthly.pdf.
11. KOMATSU, K., V. VAZ, C. MCRILL, et al. 2003. Increase in coccidioidomycosis: Arizona, 1998-2001. MMWR Morb. Mortal Wkly. Rep. 52: 109-112.
12. MOSLEY, D., K. KOMATSU, V. VAZ, et al. 1996. Coccidioidomycosis: Arizona, 1990-1995. MMWR Morb. Mortal Wkly. Rep. 45: 1069-1073.
13. LEAKE, J.A., D.G. MOSLEY, B. ENGLAND, et al. 2000. Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J. Infect. Dis. 181: 1435-1440.
14. LARWOOD, T.R. 2000. Coccidioidin skin testing in Kern County, California: decrease in infection rate over 58 years. Clin. Infect. Dis. 30: 612-613.